Companies that own Curis Inc.
First Eagle Investment Management LLC
4,980,995
15.01%
0
0.01%
06/30/2018
The Vanguard Group, Inc.
1,099,323
3.31%
-38,853
0%
06/30/2018
BlackRock Fund Advisors
804,478
2.42%
-1,017,482
0%
06/30/2018
Arnhold LLC
583,750
1.76%
-1
0.1%
06/30/2018
Renaissance Technologies LLC
474,920
1.43%
-315,000
0%
06/30/2018
GSA Capital Partners LLP
342,022
1.03%
-40,620
0.03%
06/30/2018
Millennium Management LLC
312,320
0.94%
312,320
0%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
286,839
0.86%
247,961
0%
06/30/2018
Bridgeway Capital Management, Inc.
191,140
0.57%
191,140
0%
06/30/2018
Morgan Stanley & Co. LLC
187,596
0.56%
131,040
0%
06/30/2018
| Address |
4 Maguire Road
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.curis.com |
| Updated |
07/08/2019 |
| Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. |
